Majority of Americans report no confidence in Trump to confirm vaccine safety: POLL
The numbers come via an ABC News/Ipsos poll released Sunday. — ABC News: Top Stories
News Now!, Politics
News Now!, Weather
Tropical Storm Beta moving towards Texas coast with up to 15 inches of rain possible
Tropical Storm Beta has winds of 60 mph this morning and is around 205 Miles southeast of Galveston, Texas moving west-northwest at 3 mph slowly towards the Texas coast. — ABC News: Top Stories
News Now!, Social Media & Tech.
How to erase your data to remove your life from Google’s grip
I use Google for so many things, from looking things up, handing my email and calendar, video chatting with my team, to peeking in on the Nest cam in my mother’s living room. — FOX News: Kim Komando
News Now!, Politics
Miss. Supreme Court says voters with coronavirus vulnerability don’t automatically qualify for absentee ballots
Mississippi voters more vulnerable to the coronavirus because of preexisting conditions don’t necessarily qualify to cast an absentee ballot, the state’s Supreme Court ruled Friday. — FOX News: Brie Stimson
Entertainment News, News Now!
2020 Emmys: What you need to know before the award show
As the 72nd Emmy Awards grow closer, it’s no secret that this year’s award show will be historically different from any previous broadcast of TV’s biggest night. — FOX News: Tyler McCarthy
Business, Healthcare, Local News
Opdivo® (nivolumab) in combination with CABOMETYX® (cabozantinib) demonstrates significant survival benefits in patients with advanced Renal Cell Carcinoma in pivotal Phase 3 CheckMate -9ER trial
Opdivo in combination with CABOMETYX showed superior overall survival and doubled median progression-free survival and objective response rate with a favorable safety profile vs. sunitinib Efficacy benefits were observed across key patient subgroups, including all International Metastatic Renal Cell Carcinoma Database Consortium
Business, Healthcare
Merck’s KEYTRUDA® (pembrolizumab) reduced the risk of distant metastasis or death by 40% versus placebo as adjuvant treatment in resected, high-risk stage III melanoma
Long-Term Findings From EORTC1325/KEYNOTE-054 Show Adjuvant KEYTRUDA Demonstrated a Sustained Recurrence-Free Survival Benefit Versus Placebo Across Stage IIIA (>1 mm Lymph Node Metastasis), IIIB and IIIC Melanoma Merck Is Advancing a Broad Clinical Program Evaluating KEYTRUDA for the Early Treatment of Cancer
News Now!, Sports & Gaming
Albert Pujols surpasses Willie Mays in home runs, if not dominance
Pujols’ 661st and 662nd homers are cause for celebration, and offer a chance to reflect on a career that took a wildly different trajectory than many of his elite peers. — NYT: Benjamin Hoffman
News Now!, Weather & Environment
Magnitude 4.5 earthquake rattles Southern California
The U.S. Geological Survey says a magnitude 4.5 earthquake struck Southern California late Friday night. It shook houses, rattled windows. Areas within 10 miles of Los Angeles and near El Monte, and Valencia felt its effects. — ABC News: Top Stories